Meyka AI API is live for developers.Start building.
Advertisement
Parabilis Medicines, Inc.

Parabilis Medicines, Inc. (PBLS) Stock Overview

Explore Parabilis Medicines, Inc.’s financial performance, market position, analyst ratings, and future outlook.

PBLS●NASDAQ
NaNNaN
$27.26
$3.05(10.06%)
U.S. Market opens in 5h 49m
Advertisement

Parabilis Medicines, Inc. (PBLS)

Meyka AI Score

Z

Key Financials

Market Cap89.3M
P/E RatioN/A
EPS (TTM)$-1.57
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

PBLS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Parabilis Medicines, Inc. (PBLS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 73.17, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 89.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-10.06%
5-Day Change
36.30%
1-Month Change
36.30%
3-Month Change
36.30%
6-Month Change
36.30%
Year-to-Date (YTD) Change
36.30%
1-Year Change
36.30%
3-Year Change
36.30%
5-Year Change
36.30%
All-Time (Max) Change
36.30%

Contact Information

NaN
NaN
NaN, NaN, NaN, NaN

Company Facts

CountryNaN

Frequently Asked Questions